Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 0.56 is 84% below its 5-year average of 3.44, near the low end of its 5-year range (0.56–6.00).
81.42% below its 12-month average of 3.01.
Reported quarterly EPS; no daily interpolation.
EPS growth vs the same quarter one year earlier, last 40 quarters.
EARNINGS PER SHARE (EPS)
0.56
EARNINGS PER SHARE (EPS) AVG TTM
3.01
EARNINGS PER SHARE (EPS) AVG 3Y
2.95
EARNINGS PER SHARE (EPS) AVG 5Y
3.44
EARNINGS PER SHARE (EPS) AVG 10Y
2.67
EARNINGS PER SHARE (EPS) AVG 15Y
2.36
EARNINGS PER SHARE (EPS) AVG 20Y
2.40
CURRENT VS TTM AVG
-81.42%
CURRENT VS 3Y AVG
-81.04%
CURRENT VS 5Y AVG
-83.72%
CURRENT VS 10Y AVG
-79.06%
CURRENT VS 15Y AVG
-76.28%
CURRENT VS 20Y AVG
-76.65%
Market Cap
$105.05B
Earnings Per Share (EPS)
37.37
TTM Avg
32.20
3Y Avg
28.04
5Y Avg
15.41
Market Cap
$119.21B
Earnings Per Share (EPS)
3.78
TTM Avg
2.53
3Y Avg
3.71
5Y Avg
4.39
Market Cap
$90.68B
Earnings Per Share (EPS)
29.87
TTM Avg
25.45
3Y Avg
22.39
5Y Avg
20.36
Market Cap
$125.80B
Earnings Per Share (EPS)
9.65
TTM Avg
8.18
3Y Avg
7.73
5Y Avg
6.75
Market Cap
$86.31B
Earnings Per Share (EPS)
22.50
TTM Avg
25.49
3Y Avg
25.23
5Y Avg
24.07
Market Cap
$131.37B
Earnings Per Share (EPS)
8.79
TTM Avg
7.27
3Y Avg
5.84
5Y Avg
5.20
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Sanofi (SNY) | $107.65B | 0.56 | 3.01 | 2.95 | 3.44 |
| McKesson Corporation (MCK)vs › | $105.05B | 37.37 | 32.20 | 28.04 | 15.41 |
| GSK plc (GSK)vs › | $100.82B | 3.16 | 2.69 | 4.37 | 4.18 |
| Medtronic plc (MDT)vs › | $116.98B | 3.73 | 3.69 | 3.25 | 3.23 |
| CVS Health Corp. (CVS)vs › | $119.21B | 3.78 | 2.53 | 3.71 | 4.39 |
| HCA Healthcare, Inc. (HCA)vs › | $90.68B | 29.87 | 25.45 | 22.39 | 20.36 |
| Stryker Corporation (SYK)vs › | $125.80B | 9.65 | 8.18 | 7.73 | 6.75 |
| Elevance Health Inc. (ELV)vs › | $86.31B | 22.50 | 25.49 | 25.23 | 24.07 |
| Intuitive Surgical, Inc. (ISRG)vs › | $131.37B | 8.79 | 7.27 | 5.84 | 5.20 |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $81.89B | 40.43 | 41.98 | 40.38 | 45.10 |
Trailing EPS (TTM)
$0.56
Forward EPS (Est.)
$4.18
P/E Ratio
80.5
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | 3.76 |
| 2024-12-31 | 2.27 |
| 2023-12-31 | 2.37 |
| 2022-12-31 | 3.41 |
| 2021-12-31 | 2.83 |
| 2020-12-31 | 6.00 |
| 2019-12-31 | 1.28 |
| 2018-12-31 | 1.98 |
| 2017-12-31 | 1.80 |
| 2016-12-31 | 1.92 |
| 2015-12-31 | 1.78 |
| 2014-12-31 | 2.02 |
| 2013-12-31 | 1.94 |
| 2012-12-31 | 2.44 |
| 2011-12-31 | 2.79 |
| 2010-12-31 | 2.81 |
| 2009-12-31 | 2.90 |
| 2008-12-31 | 3.83 |
| 2007-12-31 | 2.86 |
| 2006-12-31 | 1.97 |
| 2005-12-31 | 0.99 |
| 2004-12-31 | 1.49 |
| 2003-12-31 | 1.86 |
| 2002-12-31 | 1.27 |
| 2001-12-31 | 0.97 |
| 2000-12-31 | 0.64 |
| 1999-12-31 | 0.43 |
Reported annual fiscal-period values; no daily interpolation.
